Aegerion Pharmaceuticals
Aegerion Pharmaceuticals engages in the development of therapeutics and pharmaceuticals to treat cardiovascular and metabolic diseases.
Funding reportedLast round: Undisclosed round
What company datasets say Aegerion Pharmaceuticals raised
Funding, as reported
Reported in all63.7Min the source's currency
Rounds5
Last roundUndisclosed round
Last round dateOct 2010
Investors listed5
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Aegerion Pharmaceuticals in front of investors. Or tell us what we have wrong.